Sonya Gales

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Resistance Training

Nitric Oxide Synthase

Top Venues

Molecular cancer therapeutics

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Aatman S Doshi, Susan Cantin, Marylens Hernandez, Srimathi Srinivasan, Sharon Tentarelli, Matthew Griffin, Yanjun Wang, Petar Pop-Damkov, Laura B Prickett, Cecilia Kankkonen, Minhui Shen, Maryann San Martin, Song Wu, M Paola Castaldi, Hormas Ghadially, Jeffrey Varnes, Sonya Gales, David Henry, Clare Hoover, Deanna A Mele, Iain Simpson, Eric T Gangl, Scott N Mlynarski, M Raymond V Finlay, Lisa Drew, Stephen E Fawell, Wenlin Shao, Alwin G Schuller
Novel arginase inhibitor, AZD0011, demonstrates immune cell stimulation and anti-tumor efficacy with diverse combination partners. Molecular cancer therapeutics (2023)
Claire M Patterson, Srividya B Balachander, Iain Grant, Petar Pop-Damkov, Brian Kelly, William McCoull, Jeremy S Parker, Michael Giannis, Kathryn J Hill, Francis D Gibbons, Edward J Hennessy, Paul D Kemmitt, Alexander R Harmer, Sonya Gales, Stuart Purbrick, Sean Redmond, Matthew Skinner, Lorraine Graham, J Paul Secrist, Alwin G Schuller, Shenghua Wen, Ammar Adam, Corinne Reimer, Justin Cidado, Martin Wild, Eric Gangl, Stephen E Fawell, Jamal Saeh, Barry R Davies, David J Owen, Marianne B Ashford
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy. Communications biology 4 (1) (2021)